Non-steroidal anti-inflammatory drugs in the post-operative treatment of ophthalmic patients

Sergey Yurievich Astakhov , Medeya Vakhtangovna Gobedzhishvili

Ophthalmology Reports ›› 2015, Vol. 8 ›› Issue (3) : 45 -48.

PDF
Ophthalmology Reports ›› 2015, Vol. 8 ›› Issue (3) : 45 -48. DOI: 10.17816/OV2015345-48
Articles
research-article

Non-steroidal anti-inflammatory drugs in the post-operative treatment of ophthalmic patients

Author information +
History +
PDF

Abstract

Purpose: to analyze the efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) after cataract extraction. To determine the NSAID’s role in post-operative inflammatory processes treatment. Results: the rationale of NSAIDs use before and after cataract surgery was validated. The NSAIDs efficacy in terms of post-op inflammation reduction was confirmed. Among NSAIDs benefits, the convenient and easy-to-use instillation regimen of Bromfenac 0.09% eye drops solution was highlighted.

Keywords

non-steroidal anti-inflammatory drugs (NSAIDs) / arachidonic acid / cyclooxygenase / post-op trauma / cataract surgery / Bromfenac 0.09%

Cite this article

Download citation ▾
Sergey Yurievich Astakhov, Medeya Vakhtangovna Gobedzhishvili. Non-steroidal anti-inflammatory drugs in the post-operative treatment of ophthalmic patients. Ophthalmology Reports, 2015, 8(3): 45-48 DOI:10.17816/OV2015345-48

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Гобеджишвили М. В., Астахов С. Ю., Куглеев А. А. Макулярный отёк при псевдофакии. Офтальмологические ведомости, 2011; IV (4): 57-59.

[2]

Cho H., Wolf K. J., Wolf E. J. Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clinical Ophthalmology, 2009; 3: 199-210.

[3]

Donnenfeld E. D., Holland E. J., Stewart R. H., et al. Bromfenac ophthalmic solution 0,09 % (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology, 2007; 114 (9): 1653-1662.

[4]

Masuda K., Fukado Y., Shimizu H., et al. Effect of bromfenac sodium ophthalmic solution on inflammation following intraocular lens implantation. Ganka Rinsho Iho (Japanese Rev. of Clin. Ophthalmolol.), 1997; 91: 745-750.

[5]

Ogawa T., Miyake K., McNamara T. R., et al. Pharmacokinetic profile of topically applied bromfenac sodium ophthalmic solution 0,1 % in subjects undergoing cataract surgery. ARVO Annual Meeting, 2006. A687.

[6]

Waterbury L. D., Silliman D., Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr. Med. Res. Opin., 2006; 22: 1133-1140.

RIGHTS & PERMISSIONS

Astakhov S.Y., Gobedzhishvili M.V.

AI Summary AI Mindmap
PDF

149

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/